Informations techniques
Exploitant
Winthrop médicaments (Groupe Sanofi Aventis)
Présentation
DILRENE LP 300 mg, gélule à libération prolongée
B/ 28 - (Code CIP : 331 991-4)
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
B7ARxHHsvFryAU7s